Malignancy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed with cancer and receiving chemotherapy and / or radiotherapy included upon start of chemotherapy cycle. 2. Sufficient language ability to understand Japanese and to complete the questionnaire without assistance. 3. Witten informed consent
Exclusion criteria
Exclusion criteria: 1. Severe cognitive impairments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The psychometric properties, including criterion validity, construct validity, multi-trait scaling analysis, internal consistency, test-retest reliability, sensitivity, were assessed. | — |
Countries
Japan
Contacts
Tokyo University of Pharmacy and Life Sciences Department of Practical Pharmacy